Immunome, Inc.
IMNM
$7.91
$0.7410.32%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -292.96M | -305.35M | -262.59M | -232.03M | -106.81M |
| Total Depreciation and Amortization | 2.10M | 1.76M | 1.36M | 843.00K | 728.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 165.19M | 215.73M | 207.02M | 198.86M | 86.51M |
| Change in Net Operating Assets | 14.87M | 1.66M | -6.42M | -10.59M | 12.00M |
| Cash from Operations | -110.79M | -86.19M | -60.64M | -42.91M | -7.57M |
| Capital Expenditure | -53.51M | -52.48M | -4.89M | -2.89M | -831.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 9.28M | 9.28M | -25.79M | 9.28M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -31.56M | -81.62M | -153.34M | -38.93M | -38.93M |
| Cash from Investing | -85.06M | -124.82M | -148.96M | -67.61M | -30.48M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 255.76M | 235.64M | 235.13M | 233.97M | 405.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -15.23M | 40.30M | 101.38M | 101.85M | 116.00M |
| Cash from Financing | 240.53M | 275.94M | 336.51M | 335.82M | 116.41M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44.67M | 64.93M | 126.92M | 225.30M | 78.36M |